Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 9/20 | 0.61 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.44 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.43 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.43 |
| ▸ | CLK1 | P49759 | 1/20 | 0.43 |
| ▸ | CLK2 | P49760 | 1/20 | 0.43 |
| ▸ | CLK3 | P49761 | 1/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.43 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.43 |
| ▸ | TTK | P33981 | 1/20 | 0.43 |
| ▸ | MERTK | Q12866 | 4/20 | 0.43 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.42 |
| ▸ | INSR | P06213 | 1/20 | 0.42 |
| ▸ | IGF1R | P08069 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22658381 | 1.00 | LRRK2 (0.61) | LRRK2ALKDYRK3CSNK1ECLK1 | |
| SCHEMBL22658581 | 0.96 | LRRK2 (0.66) | LRRK2ALKDYRK3CSNK1ECLK1 | |
| SCHEMBL29409892 | 0.96 | LRRK2 (0.66) | LRRK2ALKDYRK3CSNK1ECLK1 | |
| SCHEMBL22658560 | 0.94 | LRRK2 (0.65) | LRRK2MERTKPTK2 | |
| SCHEMBL29409879 | 0.94 | LRRK2 (0.65) | LRRK2MERTKPTK2 | |
| SCHEMBL22658873 | 0.93 | LRRK2 (0.65) | LRRK2ALKDYRK3CSNK1ECLK1 | |
| SCHEMBL29409917 | 0.93 | LRRK2 (0.65) | LRRK2ALKDYRK3CSNK1ECLK1 | |
| SCHEMBL22658399 | 0.92 | LRRK2 (0.58) | LRRK2ALKDYRK3CSNK1ECLK1 | |
| SCHEMBL29409849 | 0.92 | LRRK2 (0.58) | LRRK2ALKDYRK3CSNK1ECLK1 | |
| SCHEMBL22658576 | 0.92 | LRRK2 (0.57) | LRRK2ALKDYRK3CSNK1ECLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3968990-A1 | PYRROLOPYRIMIDINE INHIBITORS OF WILD-TYPE AND MUTANT FORMS OF LRRK2 | Dana-Farber Cancer Institute, Inc. (US) | 2022-03-23 | — | — | EP | disclosed |